Cancer cells employ lipid droplets to survive toxic stress
The Prostate · 2024
DOI: 10.1002/pros.24680 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Laurie G Kostecka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Lipid Droplets, Prostatic Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH/NCI, CDMRP/PCRP, Prostate Cancer Foundation.
Abstract (Originalsprache)
Background
Lipid reprogramming is a known mechanism to increase the energetic demands of proliferating cancer cells to drive and support tumorigenesis and progression. Elevated lipid droplets (LDs) are a well‐known alteration of lipid reprogramming in many cancers, including prostate cancer (PCa), and are associated with high tumor aggressiveness as well as therapy resistance. The mechanism of LD accumulation and specific LD functions are still not well understood; however, it has been shown that LDs can form as a protective mechanism against lipotoxicity and lipid peroxidation in the cell.
Methods
This study investigated the significance of LDs in PCa. This was done by staining, imaging, image quantification, and flow cytometry analysis of LDs in PCa cells. Additionally, lipidomics and metabolomics experiments were performed to assess the difference of metabolites and lipids in control and treatment surviving cancer cells. Lastly, to assess clinical significance, multiple publicly available datasets were mined for LD‐related data.
Results
Our study demonstrated that prostate and breast cancer cells that survive 72 h of chemotherapy treatment have elevated LDs. These LDs formed in tandem with elevated reactive oxygen species levels to sequester damaged and excess lipids created by oxidative stress, which promoted cell survival. Additionally, by inhibiting diacylglycerol O ‐acyltransferase 1 (DGAT1) (which catalyzes triglyceride synthesis into LDs) and treating with chemotherapy simultaneously, we were able to decrease the overall amount of LDs and increase cancer cell death compared to treating with chemotherapy alone.
Conclusions
Overall, our study proposes a potential combination therapy of DGAT1 inhibitors and chemotherapy to increase cancer cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
- Johns Hopkins School of Medicine, Cancer Ecology Center, The James Brady Urological Institute, Baltimore, Maryland, USA.
- Cellular and Molecular Medicine Program, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
- Pharmacology and Molecular Sciences Program, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Laurie G Kostecka, Sarah R Amend
Förderung
- NIH/NCI
- CDMRP/PCRP
- Prostate Cancer Foundation
- Nanotechnology for Cancer Research Program
Zitieren
APA
Kostecka, L. G., Mendez, S., Li, M., Khare, P., Zhang, C., Le, A., Amend, S. R., & Pienta, K. J. (2024). Cancer cells employ lipid droplets to survive toxic stress. The Prostate. https://doi.org/10.1002/pros.24680
Vancouver
Kostecka LG, Mendez S, Li M, Khare P, Zhang C, Le A, et al. Cancer cells employ lipid droplets to survive toxic stress. The Prostate. 2024. doi:10.1002/pros.24680
BibTeX
@article{Kostecka2024,
author = {Kostecka, Laurie G and Mendez, Sabrina and Li, Melvin and Khare, Pratik and Zhang, Cissy and Le, Anne and Amend, Sarah R and Pienta, Kenneth J},
title = {Cancer cells employ lipid droplets to survive toxic stress},
journal = {The Prostate},
year = {2024},
doi = {10.1002/pros.24680}
}
EUVIMED